Stockholders approved the exercise of warrants to purchase up to 949,310 shares of Class A Common Stock. The warrants became exercisable immediately following the April 23, 2026, Annual Meeting. The warrants include Series A (460,830 shares), Series B (460,830 shares), and placement agent warrants (27,650 shares), all with an exercise price of approximately $2.17 per share. Series A Warrants expire on October 23, 2031, and Series B Warrants expire on October 25, 2027.